This indicates that elevated C-reactive protein levels are associated with an increased risk of death, confirming that severe systemic inflammation, as reflected by elevated C-reactive protein values, may contribute to a poorer prognosis among elderly patients with COVID-19. This evidence concerns the gene CRP and COVID-19.